Blood Type May Offer Insights into Risk of Blood Clot in People with Cancer

Scientists have long strived to understand the risk factors for VTE, the leading cause of preventable hospital deaths in the United States. Existing assessments use factors like tumor or cancer type to detect those at high risk of VTE. Yet, many patients without these diagnoses still develop life-threatening blood clots but go unidentified.

Related Keywords

Vienna ,Wien ,Austria ,United States ,Washington ,American ,Cornelia Englisch ,American Society Of Hematology ,University Of Vienna ,Blood Advancesstudy ,Vienna Cancer ,Thrombosis Study ,Medical University ,American Society ,Biomarker ,Blood ,Brain Tumor ,Cancer ,Hematology ,Medical Specialties ,Clinical Medicine ,Deep Vein Thrombosis ,Pulmonary Embolism ,Thrombosis ,Thrombosis Prevention ,Venous Thrombosis ,